.png)
Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.
What You’ll Learn:
- Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.
- Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.
- Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.
Why Listen?
- Actionable Playbooks: Reverse-engineer success stories from startups that enrolled cohorts 50% faster and secured Series B funding 12–18 months early.
- Regulatory Intel: Stay ahead of shifting LATAM, Balkans, and APAC guidelines with on-the-ground experts.
- Future-Proof Insights: Explore decentralized trials, AI-driven recruitment, and post-trial commercialization in $1B+ markets.
“bioaccess®’s Serbia site activated in 8 weeks-9 months faster than our EU delay.
This podcast is why we partnered with them.”
– Digital Health Startup CEO
New episodes drop weekly. Subscribe to unlock your shortcut to global trial velocity.
Brought to you by bioaccess® – Turning “anywhere” into accelerated FDA/EMA submissions since 2010.
Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
Latest Episodes
Matt DeNardo, Chief Product Officer at Axoft
In this episode, we’re joined by Matt DeNardo, a biomedical engineer and product development leader with a passion for transforming complex clinical challenges into innovative medical technologies.Matt shares how his approach comb...
Daniel Chen, Founder and CEO at Synthetic Design Lab
In this episode of Global Trial Accelerators, we speak with Daniel S. Chen, MD, PhD, Founder and CEO of Synthetic Design Lab and former Global Head of Cancer Immunotherapy Development at Genentech/Roche.Daniel shares insights from his pi...
Shareef Mahdavi, Founder at PX Movement
Shareef Mahdavi joins the podcast to discuss how patient experience directly impacts practice growth, referrals, and retention. He shares the strategies that helped transform Laser Eye Center of Silicon Valley by improving how patients fe...
Joseph Geraci, CSO/CTO & Co-Founder at NetraMark
In this episode, we sit down with Dr. Joseph Geraci — mathematical physicist, medical scientist, and AI innovator — to explore how artificial intelligence is transforming the future of medicine and clinical research.Dr. Geraci began his ...
Gary Zammit, President & CEO at Clinilabs Drug Development Corporation
In this episode, we welcome Gary K. Zammit, a leading expert at the intersection of science, business, and innovation in the life sciences industry.Gary is the founder and CEO of Clinilabs, a CNS-focused contract research organization, a...
